Followers | 33 |
Posts | 12837 |
Boards Moderated | 0 |
Alias Born | 08/29/2012 |
![](https://investorshub.advfn.com/uicon/358504.png?cb=1619682600)
Monday, June 03, 2019 4:44:09 AM
1. All 4 job openings on Elite's website were removed in one day with one click of the mouse.
2. Elite never announced the launch of Generic Adderall. They have always announced the launch of new drugs 100% of the time. Even though it is owned 50/50 with SunGen, it is Elite's biggest drug launch to date.
3. Elite never announced or updated their website with the Elite/SunGen #4 filing. This product is Elite/SunGen's 2nd antibiotic product and 4th product overall. This filing was due in March at the very latest, with previous CC's stating a "January/February" filing timeline. Positive BE results for this drug were reported back in October 2018.
Compare this to the timeline of Elite/SunGen's 1st antibiotic product.
Elite/SunGen's 1st antibiotic product:
August 14, 2018: Positive BE results reported.
January 3, 2019: FILED
Total Days: 142
Elite/SunGen's 2nd antibiotic product:
October 23, 2018: Positive BE results reported.
NOT FILED ACCORDING TO PUBLIC INFO
Total Days: 223 days and counting
4. Elite never announced the FDA approval of DANTROLENE SODIUM on February 27, 2019.
5. Elite never announced the launch of any of the generics transferred from Epic to Glenmark.
6. Elite never announced the new patent earlier this year.
7. No update on the annual shareholder meeting. No PR's or SEC filings. Nasrat on the February CC: "We are starting the process." Carter: "The whole process will take roughly 4 months once it starts." So has it started or hasn't it???
--- Numbers 4-7 are not THAT big of a deal.
--- Numbers 1-3 are EXTREMELY fishy.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM